Hsiehchen, David
Goralski, Maria
Kim, Jiwoong
Xie, Yang
Nijhawan, Deepak
Funding for this research was provided by:
American Society of Hematology
U.S. Department of Health & Human Services | National Institutes of Health (R37CA226771)
Welch Foundation (I-1879)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (RO1CA217333)
Article History
Received: 19 September 2019
Revised: 20 December 2019
Accepted: 28 January 2020
First Online: 10 February 2020
Compliance with ethical standards
:
: DN is a consultant for Peloton Therapeutics, now a wholly owned subsidiary of Merck. The other authors declare no conflict of interest.